A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.
Einsele H, Bamberg M, Budach W, Schmidberger H, Hess CF, Wörmann B, Meisner C, Straka C, Hebart H, Trümper L, Kröger N, Zander AR, Hegewisch-Becker S, Hossfeld DK, Schmidt H, Müller P, Schlimok G, Hertenstein B, Peest D, Metzner B, Frickhofen N, Kanz L, Bensinger WI.
Einsele H, et al. Among authors: hess cf.
Bone Marrow Transplant. 2003 Sep;32(6):593-9. doi: 10.1038/sj.bmt.1704192.
Bone Marrow Transplant. 2003.
PMID: 12953132
Clinical Trial.